Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.

Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:


Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

CompanyDrug NameStatusIndication Group
Nektar Therapeutics Macugen Approved in Canada and BrazilSensory organs
OSI Macugen Approved in USA, EU, Canada and BrazilSensory organs
Pfizer Macugen Approved in Canada and BrazilSensory organs
Roche MABTHERA in Phase IIINervous system
Roche MABTHERA Approved in EUAntineoplastic & immunomodulating agents
Pfizer Lyrica Approved in USANervous system
Human Genome Sciences LymphoStat-B accomplished Phase IIMusculoskeletal system
Human Genome Sciences LymphoStat-B discontinuedAntineoplastic & immunomodulating agents
Immunomedics LymphoCide accomplished Phase IIIAntineoplastic & immunomodulating agents
Takeda Lupron Depot US / Enantone EU;Asia / Leuplin Japan Submitted for approval in EUAntineoplastic & immunomodulating agents
Allergan LUMIGAN Approved in USASensory organs
Genentech Lucentis Approved in USA, submitted in EUSensory organs
NovaRx Lucanix accomplished Phase IIAntineoplastic & immunomodulating agents
Novartis Lotrel Accomplish in Phase IIICardiovascular system
Dainippon Sumimoto Pharma Lonasen Submitted for approval in JapanNervous system
Genaera Lomucin discontinuedRespiratory system
Schering-Plough Livial in Phase IIIGenito urinary system & sex hormones
Visient Therapeutics Litx in Phase ISensory organs
Medivir Lipsovir in Phase IIIAnti-infectives for systemic use
Endovasc Liprostin accomplished Phase IICardiovascular system

Drug Pipeline Copyright © 2005- 2018 All Rights Reserved.